Geely's acquisition of Volvo, Tongyuan Petroleum Holdings Yongchen Technology, German Krass Group's merger and acquisition of Jinyi ... In the context of the Chinese market linking the world and joining the sixth wave of global mergers and acquisitions, Daqing's industrial economy has completed several mergers and acquisitions Benefit a lot. In the next few years, launching transnational technology mergers and acquisitions in Europe, and attracting domestic leading enterprises, and integrating and integrating local enterprises in Daqing, will become an important path for Daqing's economic transformation and upgrading and optimization of stock.
Entering 2015, the Daqing biopharmaceutical industry will face a large-scale merger and reorganization. Jilin Amendment Pharmaceutical, one of the top 500 domestic private enterprises and the second largest domestic pharmaceutical company, is planning to acquire two pharmaceutical companies, Daqing Huake Pharmaceutical and Tianyi Pharmaceutical, and has conducted several rounds of negotiations. At present, Amend Pharmaceutical is in-depth docking with Tianyi Pharmaceutical on the products of Isatis Indigotica deep processing and Homage grass deep processing.
Tianyi Pharmaceutical's industrial foundation and core technology are not weak, the difference is the brand and capital. Fixed that if the pharmaceutical industry controls Tianyi, it will bring multiple benefits to Tianyi. Firstly, funds will be very abundant in expanding production capacity. Secondly, Tianyi's medicines will be sold by modifying the brand effect of the pharmaceutical industry, and the market can expand rapidly. More importantly, revising the technology research and development resources and modern business management concepts of the pharmaceutical industry can greatly promote the transformation and upgrading of Tianyi Pharmaceutical's core competitiveness.
Daqing Huake Pharmaceutical is a subsidiary of Daqing Huake Co., Ltd., and its core products are not weak, but its development has been sluggish in recent years. If it is acquired by Amend Pharmaceutical, it can also achieve a gorgeous turn.
And once the correction pharmaceutical industry completes the acquisition, it will build a pharmaceutical industry park in Daqing, and the Daqing biopharmaceutical industry will add new growth poles after the Freebion Biotechnology Industrial Park.
Dong Shenghui, chief economist of Daqing High-tech Zone, believes that "no matter whether it is a merger or acquisition, it is a good thing. It is a reasonable way to optimize the allocation of resources and promote industrial upgrading."
After more than 20 years of development in Daqing's non-oil economy, especially the leap-forward growth in recent years, it has achieved a certain degree of accumulation of capital, markets, and talents, and has the ability and desire to improve the technological level and implant the value of the brand . Daqing's industrial economy needs to seize the opportunity in this wave of mergers and acquisitions to obtain more practical and mature technology, so as to achieve the upgrade from enterprise to industry.
(From Daqing Daily)